WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
50268-0761-12	None	TEMOZOLOMIDE, 20 MG, ORAL	TEMOZOLOMIDE (4 X 5) 20 MG	PO
50268-0762-11	None	TEMOZOLOMIDE, 100 MG, ORAL	TEMOZOLOMIDE (INNERPACK) 100 MG	PO
50268-0762-12	None	TEMOZOLOMIDE, 100 MG, ORAL	TEMOZOLOMIDE 100 MG	PO
50268-0763-11	None	TEMOZOLOMIDE, 20 MG, ORAL	TEMOZOLOMIDE (INNERPACK) 140 MG	PO
50268-0763-12	None	TEMOZOLOMIDE, 20 MG, ORAL	TEMOZOLOMIDE 140 MG	PO
50383-0040-04	J7510	PREDNISOLONE ORAL, PER 5 MG	PREDNISOLONE SODIUM PHOSPHATE (AF,SF,DYE-FREE) 5 MG/5 ML	PO
50383-0042-24	J7510	PREDNISOLONE ORAL, PER 5 MG	PREDNISOLONE 15 MG/5 ML	PO
50383-0042-48	J7510	PREDNISOLONE ORAL, PER 5 MG	PREDNISOLONE 15 MG/5 ML	PO
50383-0741-20	J7611	ALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, 1 MG	ALBUTEROL SULFATE 0.5%	IH
50383-0801-16	Q0169	PROMETHAZINE HYDROCHLORIDE, 12.5 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN	PROMETHAZINE HCL (CHERRY) 6.25 MG/5 ML	PO
50383-0810-16	J8499	PRESCRIPTION DRUG, ORAL, NON CHEMOTHERAPEUTIC, NOS	ACYCLOVIR (BANANA) 200 MG/5 ML	PO
50419-0385-01	J3490	UNCLASSIFIED DRUGS	ALIQOPA (LYOPHILIZED) 60 MG	IV

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N